144 related articles for article (PubMed ID: 24270968)
1. Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results.
Schiffmann J; Fischer J; Tennstedt P; Beyer B; Böhm K; Michl U; Graefen M; Salomon G
World J Urol; 2014 Aug; 32(4):939-44. PubMed ID: 24270968
[TBL] [Abstract][Full Text] [Related]
2. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.
Schiffmann J; Tennstedt P; Fischer J; Tian Z; Beyer B; Boehm K; Sun M; Gandaglia G; Michl U; Graefen M; Salomon G
World J Urol; 2014 Aug; 32(4):925-30. PubMed ID: 24871425
[TBL] [Abstract][Full Text] [Related]
3. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™.
Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A
Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomy.
Salomon G; Spethmann J; Beckmann A; Autier P; Moore C; Durner L; Sandmann M; Haese A; Schlomm T; Michl U; Heinzer H; Graefen M; Steuber T
BJU Int; 2013 Jan; 111(1):60-6. PubMed ID: 22882794
[TBL] [Abstract][Full Text] [Related]
5. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
6. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics.
Morozov A; Kozlov V; Rivas JG; Teoh JY; Bezrukov E; Amosov A; Barret E; Taratkin M; Salomon G; Herrmann TRW; Gozen A; Enikeev D;
World J Urol; 2021 Oct; 39(10):3733-3740. PubMed ID: 33825986
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer.
Konyalioglu E; Tarhan H; Cakmak O; Pala EE; Zorlu F
Int Braz J Urol; 2015; 41(3):442-8. PubMed ID: 26200537
[TBL] [Abstract][Full Text] [Related]
9. [Value of perineal HistoScanning™ template-guided prostate biopsy].
Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
[TBL] [Abstract][Full Text] [Related]
10. Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.
Schiffmann J; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Graefen M; Hammerer P; Salomon G
World J Urol; 2015 Dec; 33(12):1993-9. PubMed ID: 25860379
[TBL] [Abstract][Full Text] [Related]
11. HistoScanning
Wysock JS; Xu A; Orczyk C; Taneja SS
Curr Urol Rep; 2017 Oct; 18(12):97. PubMed ID: 29064054
[TBL] [Abstract][Full Text] [Related]
12. Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.
Omri N; Kamil M; Alexander K; Alexander K; Edmond S; Ariel Z; David K; Gilad AE; Azik H
Prostate; 2020 Dec; 80(16):1444-1449. PubMed ID: 32970856
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
14. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
Schiffmann J; Mehring G; Tennstedt P; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Hammerer P; Graefen M; Salomon G
World J Urol; 2016 Apr; 34(4):495-500. PubMed ID: 26215749
[TBL] [Abstract][Full Text] [Related]
15. Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.
Núñez-Mora C; García-Mediero JM; Patiño P; Orellana C; Garrido A; Rojo A; Rendón D
Actas Urol Esp; 2013 Jun; 37(6):342-6. PubMed ID: 23507291
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
17. Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies.
Covin B; Roumiguié M; Quintyn-Ranty ML; Graff P; Khalifa J; Aziza R; Ploussard G; Portalez D; Malavaud B
World J Urol; 2019 Feb; 37(2):269-275. PubMed ID: 30145777
[TBL] [Abstract][Full Text] [Related]
18. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate volume measured by transabdominal ultrasound and MRI with the radical prostatectomy specimen volume: a retrospective observational study.
Guo S; Zhang J; Jiao J; Li Z; Wu P; Jing Y; Qin W; Wang F; Ma S
BMC Urol; 2023 Apr; 23(1):62. PubMed ID: 37069539
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.
Sajadi KP; Terris MK; Hamilton RJ; Cullen J; Amling CL; Kane CJ; Presti JC; Aronson WJ; Freedland SJ
J Urol; 2007 Sep; 178(3 Pt 1):990-5. PubMed ID: 17632170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
